Boosting AI to read chest X-rays smarter and more accurately

Bagging up and disposing of your pet's poo is a necessary, albeit unpleasant, part of responsible pet ownership. But a new UK government initiative will be asking people to send them their pets' poo instead of throwing it away.

Microbes in our gut are important for overall health, but certain bacteria can promote inflammation, damage DNA, and support the growth of diseases like cancer.

Non-antibiotic drugs can alter the microbiome and increase the risk of gut infections in surprising ways, a new Nature study shows.

Plastics are everywhere—they're even in you right now—and are making many of us sick. Now, global negotiators are fighting over whether that matters.

Researchers from Helmholtz Munich, the Technical University of Munich (TUM), and the Medical University of Vienna have developed an advanced imaging technique called "O2E" that allows clinics to detect cancerous lesions in the esophagus with unprecedented precision.

A cross-sectional analysis from Yale School of Medicine estimates that approximately 5.8 million adolescents and 11.1 million young adults in the United States meet eligibility criteria for glucagon-like peptide-1 receptor agonists (GLP-1RAs), drugs approved to treat obesity and type 2 diabetes (T2D) in some pediatric populations.

The mitral valve controls blood flow between the heart's left atrium and ventricle. When structural changes affect the atrium or valve, it may not close fully—causing blood to leak backwards, a condition known as atrial functional mitral regurgitation (AFMR). Common in frail or elderly patients, AFMR often leads to heart failure, and standard surgery is typically too risky due to other health issues.

Children whose mothers had diabetes in pregnancy—gestational and pre-existing—do not have an increased risk of developmental vulnerability or lower educational outcomes, a new University of Melbourne study has found.

A study published in Cell Reports Medicine reports a scalable, data-driven computational framework for designing combinatorial immunotherapies, offering hope for patients with poor responses to current immunotherapies.

Connecticut is now participating in a new federal program aimed at expanding treatment access for patients with sickle cell disease who are insured through Medicaid.

A new study conducted across five U.K. air ambulance services has revealed significant variation in calcium levels among trauma patients receiving pre-hospital blood transfusions—highlighting a critical opportunity to provide more tailored care for patients.

At the Two Spirit Conference in northern Nevada in June, Native Americans gathered in support of the LGBTQ+ community amid federal and state rollbacks of transgender protections and gender-affirming health care.

When the human body overheats, the consequences can be deadly. Heat stroke, heart attacks, kidney failure, and worsening of existing conditions like cardiovascular and respiratory diseases are just some of the ways extreme heat can push the body past its limits.

It is already well known that when a mother experiences inflammation during pregnancy, her child is more likely to develop allergic diseases. Recently, a KAIST research team became the first in the world to discover that inflammation within the placenta affects the fetus's immune system, leading to the child exhibiting excessive allergic reactions after birth.

The Trump administration is escalating its push against what has become a key part of the way states, localities and communities respond to the overdose epidemic: harm reduction.

Needless fear of hair loss and brittle, discolored nails caused by cancer treatment might lead many patients to avoid or delay life-saving treatment, a new pilot study says.

The new toolkit is designed to support the implementation and scale-up of hepatitis B and C interventions in prisons across Europe. It also reinforces the principle of "equivalence of care," ensuring that people in prison receive health care comparable to that available in the community.

Researchers at the University of California, Irvine have identified a promising nonpharmaceutical treatment that rejuvenates aging brain cells and clears away the buildup of harmful proteins associated with Alzheimer's disease.